Recommended Dosage of Naloxone for Adults
The recommended initial dose of naloxone for opioid overdose in adults is 0.4 mg to 2 mg intravenously, which may be repeated every 2-3 minutes until respiratory function improves. 1
Route-Specific Dosing
Intravenous (IV) Administration
- Initial dose: 0.4 mg to 2 mg 1
- May repeat every 2-3 minutes as needed 1
- If no response after 10 mg total, question diagnosis of opioid-induced toxicity 1
- For postoperative opioid depression: Use smaller doses (0.1 to 0.2 mg) titrated at 2-3 minute intervals 1
Intramuscular (IM) or Subcutaneous (SC) Administration
- Use when IV access is unavailable 2
- Same dosing as IV: 0.4 mg to 2 mg initially 2
- May repeat as needed every 2-3 minutes 2
Intranasal (IN) Administration
- Most studies used a fixed dose of 2 mg, repeated in 3-5 minutes if necessary 3
Special Considerations
Opioid-Dependent Patients
- Consider lower initial doses (0.04-0.4 mg) to avoid precipitating severe withdrawal 3, 4
- Withdrawal symptoms may include hypertension, tachycardia, vomiting, agitation, and drug cravings 3
- Cautious dosing is warranted as high-dose naloxone may cause catecholamine release leading to pulmonary edema and cardiac arrhythmias in patients treated for severe pain 5
Duration of Action
- Half-life of naloxone is 30-45 minutes 3
- Supplemental doses may be required after 20-30 minutes 3
- The effect of naloxone may wear off before the opioid effect, requiring continued monitoring 5
- Repeat doses or continuous infusion may be necessary for long-acting opioids 2
Continuous Infusion
- May dilute 2 mg naloxone in 500 mL of 0.9% sodium chloride or 5% dextrose (concentration: 0.004 mg/mL) 2
- Use within 24 hours 2
- Titrate rate according to patient response 2
Common Pitfalls to Avoid
- Delaying CPR while searching for naloxone in cardiac arrest patients 4
- Premature discharge after naloxone response without adequate observation 4
- Focusing on awakening rather than adequate ventilation 4
- Inadequate dosing when dealing with potent synthetic opioids 4
- Failing to recognize that naloxone will not reverse effects of non-opioid substances in polysubstance overdose 4
- Administering too high a dose in opioid-dependent patients, causing severe withdrawal 6
Treatment Algorithm
- Assess responsiveness and breathing
- Begin rescue breathing if necessary
- Administer appropriate naloxone dose based on route and patient status
- Reassess after 2-3 minutes
- Repeat dosing as needed until adequate respiratory function is achieved
- Monitor for at least 1-2 hours after last dose due to naloxone's shorter duration compared to many opioids 4
Naloxone is a safe medication with a wide therapeutic window, but careful dose titration is important to balance reversal of respiratory depression with minimizing withdrawal symptoms in opioid-dependent individuals.